首页 > 市场调查报告书 > 工业机械

机械元件流体机器阀门

市场调查报告书

商品编码

1873998

牛心包瓣膜市场

Bovine Pericardial Valve Market

出版日期: 2025年11月01日 | 出版商:

The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格

简介目录

牛心包瓣膜市场预计将从2024年的31.4亿美元成长到2031年的60.8亿美元，2031年至2031年的年复合成长率（CAGR）为9.9%。心臟瓣膜手术报销额的增加预计将成为牛心包瓣膜市场的重要趋势。

牛心包瓣膜市场分析

牛心包瓣膜广泛应用于各种医疗领域，包括生物人工心臟瓣膜、硬脑膜闭合、牙科和骨膜以及外科手术加强。心臟瓣膜手术数量的不断增加有望促进旨在改善患者预后的创新疗法的研发。

牛心包瓣膜市场概览

由于牛心包瓣膜相比机械瓣膜具有诸多优势，其在心血管手术（例如主动脉瓣置换术和先天性心臟病治疗）的需求日益增长。这些生物瓣膜，包括牛心包瓣膜，可用于微创手术和开胸手术。这些瓣膜的一个关键优势在于，它们无需终身服用华法林（机械瓣膜患者为预防血栓而必须服用），从而降低了选择生物瓣膜患者的中风或栓塞风险。此外，生物瓣膜尤其适用于老年患者，因为老年患者在瓣膜置换手术中更容易受到华法林相关出血风险的影响。因此，预计牛心包生物瓣膜相对于机械瓣膜的优势将在整个预测期内推动市场成长。

牛心包瓣膜市场的驱动因素与机会

心臟瓣膜疾病发生率上升将推动市场成长

全球主动脉瓣置换手术数量的成长推动了对牛心包瓣膜的需求。 2024年1月发表于《跨学科心血管和胸腔外科杂誌》的一项研究分析了一项临床试验，该试验纳入了148例接受Cingular牛心包膜生物瓣膜主动脉瓣置换术的患者。五年的追踪结果表明，这种创新的牛心包主动脉瓣膜具有良好的安全性和血流动力学效果。

拓展应用－儿科和先天性心臟病领域的机会

牛心包瓣膜也用于儿童心臟瓣膜置换和先天性心臟缺陷的修復。 2023年4月发表在Springer Link上的文章指出，牛心包经常被用作自体心包的替代品。牛心包膜材料（包括补片）的耐久性取决于手术技术和植入部位。使用牛心包瓣膜的手术取得的积极成果有望促使人们开发出专为儿童设计的特殊瓣膜样式和尺寸，从而为牛心包瓣膜市场带来未来的发展机会。

牛心包瓣膜市场細項分析

对牛心包瓣膜市场进行分析的关键细分市场包括瓣膜类型、合金和最终用户。

市场按瓣膜类型分为主动脉瓣、二尖瓣和其他瓣膜，其中主动脉瓣在 2023 年占据最大的市场份额。
依合金种类划分，市场分为钴铬合金、钛合金、镍钼合金和其他合金，其中钴铬合金在 2023 年占据市场份额领先地位。
从最终用户来看，市场分为医院、心臟中心和门诊手术中心，其中医院在 2023 年占据市场主导地位。

牛心包瓣膜市场的地理分析

牛心包瓣膜市场报告的地理范围分为五个区域：北美、亚太、欧洲、中东和非洲以及南美和中美洲。

北美一直是牛心包瓣膜市场的领先地区，这主要得益于心血管疾病和先天性心臟缺陷盛行率的上升，以及主要市场参与者的存在。生物瓣膜（例如牛心包瓣膜）作为心臟介入手术中机械瓣膜的替代方案，其应用日益广泛，预计将进一步推动北美市场成长。此外，由于医疗旅游业的兴起和医院数量的增加，加拿大和墨西哥也预计将迎来成长机会。预计亚太地区在未来几年将实现最高的复合年增长率。

牛心包瓣膜市场报告范围

牛心包瓣膜市场的最新发展

牛心包瓣膜市场评估是基于从一手和二手研究中收集的定性和定量资料，包括重要的企业出版物、协会资料和资料库。牛心包瓣膜市场的最新发展包括：

美敦力公司推出了Avalus Ultra瓣膜，设计为方便植入和长期患者管理。这款新一代外科主动脉组织瓣膜采用聚醚醚酮（PEEK）基座框架，确保瓣膜的圆度一致性；拥有业界领先的有效瓣口面积（EOA），可增强血流；并配备不透射线的线圈，以提高未来瓣中瓣手术的可见度（来源：美敦力公司，新闻稿，2024）。
爱德华生命科学公司推出了SAPIEN 3 Ultra RESILIA瓣膜，将该公司的RESILIA组织技术与SAPIEN 3 Ultra经导管主动脉心臟瓣膜结合。 RESILIA组织是采用先进抗钙化技术处理的牛心包组织，是包括目前正在进行临床试验的下一代SAPIEN X4瓣膜在内的新型瓣膜的基础（资料来源：爱德华生命科学公司网站，2022年）。

牛心包瓣膜市场报告的覆盖范围和交付成果

这份题为《牛心包瓣膜市场规模及预测（2021-2031）》的报告对市场进行了全面分析，涵盖以下领域：

涵盖范围内所有关键细分市场的全球、区域和国家层面的市场规模和预测。
市场动态，包括驱动因素、限制因素和主要机会。
未来主要趋势。
详细的PEST/波特五力模型和SWOT分析。
全球及区域市场分析，重点在于关键趋势、主要参与者、法规及最新发展。
产业格局和竞争分析，包括市场集中度、热力图分析、主要参与者和最新发展。
深入的公司概况。

市场驱动因素
- 心血管疾病（CVD）和先天性心臟病（CHD）发生率不断上升
- 组织瓣膜相对于机械瓣膜的优势
市场限制
- 组织瓣膜的局限性
市场机会
- 全球医疗保健产业发展
未来趋势
- 心臟瓣膜手术报销额不断增长
驱动因素和约束措施的影响分析

第六章：牛心包瓣膜市场及全球分析

全球牛心包瓣膜市场收入预测与分析
全球牛心包瓣膜市场（依地理划分）－预测与分析
关键参与者的市场定位

第七章：牛心包瓣膜市场分析及瓣膜类型

概述
2024 年及 2031 年牛心包瓣膜市场份额（按瓣膜类型划分）
主动脉
二尖瓣
其他的

第八章：牛心包瓣膜市场分析及合金分类

概述
2024 年及 2031 年牛心包瓣膜市场占有率（依合金类型划分）
钴铬合金
钛
镍钼
其他的

第九章：牛心包瓣膜市场分析及最终用户细分

概述
2024 年及 2031 年牛心包瓣膜市场份额（按最终用户划分）
医院
心臟中心
门诊手术中心

第十章：牛心包瓣膜市场分析及至2031年预测及地理分析

北美洲
- 我们
- 加拿大
- 墨西哥
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
亚太地区
- 中国
- 日本
- 印度
- 韩国
- 澳洲
中东和非洲
- 沙乌地阿拉伯
- 阿联酋
- 南非
南美洲和中美洲
- 南美洲和中美洲
- 巴西
- 阿根廷

第十一章：新冠肺炎疫情对全球牛心包瓣膜市场的影响

北美洲：新冠肺炎疫情影响评估
欧洲：新冠肺炎疫情影响评估
亚太地区：新冠肺炎疫情影响评估
世界其他地区：新冠肺炎疫情影响评估

第十二章：行业概况

概述
市场中各公司采取的成长策略（%）
有机和无机发展
- 概述

第十三章：公司简介

Abbott
AFFLUENT MEDICAL SA
Boston ScientificCorporation
Braile Biomedica
Edwards LifesciencesCorporation
Labcor
LivaNova PLC
Medtronic
Meril Life SciencesPvt. Ltd.
Valcare Medical

第十四章：附录

简介目录

Product Code: TIPRE00008677

The bovine pericardial valve market is anticipated to grow from US$ 3.14 billion in 2024 to US$ 6.08 billion by 2031, reflecting a compound annual growth rate (CAGR) of 9.9% from 2031 to 2031. An increase in reimbursement for cardiac valve surgeries is expected to be a significant trend in the bovine pericardial valve market.

Analysis of the Bovine Pericardial Valve Market

Bovine pericardial valves are extensively utilized in various medical fields, including bio-prosthetic heart valves, dural closure, dental and bone membranes, and surgical buttressing. The rising number of heart valve interventions is likely to promote the development of innovative treatments aimed at enhancing patient outcomes.

Overview of the Bovine Pericardial Valve Market

The demand for bovine pericardial valves in cardiovascular procedures, such as aortic valve replacements and treatments for congenital heart defects, is increasing due to their benefits compared to mechanical valves. These tissue valves, including those made from bovine pericardium, can be employed in both minimally invasive and open-heart surgeries. A key advantage of these valves is that they eliminate the need for lifelong warfarin therapy, which is necessary to prevent blood clots with mechanical valves, thereby reducing the risk of stroke or embolism for patients who choose tissue valves. Additionally, bioprosthetic valves are particularly suitable for elderly patients, who are more susceptible to the bleeding risks associated with warfarin during valve replacement procedures. Consequently, the benefits of bovine pericardial bioprosthetic heart valves over mechanical options are expected to drive market growth throughout the forecast period.

Drivers and Opportunities in the Bovine Pericardial Valve Market

Increasing Incidence of Heart Valve Diseases to Boost Market

The global rise in aortic valve replacement surgeries is fueling the demand for bovine pericardial valves. A study published in the Interdisciplinary CardioVascular and Thoracic Surgery in January 2024 analyzed a clinical trial involving 148 patients who underwent surgical aortic valve replacement with Cingular bovine pericardial bioprosthesis. The five-year follow-up indicated that this innovative bovine pericardial aortic valve demonstrated favorable safety and hemodynamic results.

Expanding Uses - Opportunities in Pediatric and Congenital Heart Conditions

Bovine pericardial valves are also utilized in pediatric heart valve replacements and repairs for congenital heart defects. An article published in Springer Link in April 2023 noted that bovine pericardium is frequently used as an alternative to autologous pericardium. The durability of bovine pericardial materials, including patches, varies based on the surgical technique and implantation site. The positive outcomes from surgeries using bovine pericardial valves are expected to lead to the creation of specialized valve designs and sizes for children, presenting future opportunities for the bovine pericardial valve market.

Segmentation Analysis of the Bovine Pericardial Valve Market

Key segments contributing to the analysis of the Bovine Pericardial Valve Market include valve type, alloy, and end user.

The market is categorized by valve type into aortic, mitral, and others, with the aortic segment holding the largest market share in 2023.
By alloy, the market is divided into cobalt-chrome, titanium, nickel molybdenum, and others, with cobalt-chrome leading the market share in 2023.
In terms of end users, the market is segmented into hospitals, cardiac centers, and ambulatory surgical centers, with hospitals dominating the market in 2023.

Geographical Analysis of the Bovine Pericardial Valve Market

The geographical scope of the bovine pericardial valve market report is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America has been the leading region in the Bovine Pericardial Valve Market, driven by the rising prevalence of cardiovascular diseases, congenital heart defects, and the presence of major market players. The increasing adoption of bioprostheses, such as bovine pericardial valves, as alternatives to mechanical valves for heart interventions is expected to further enhance market growth in North America. Additionally, growth opportunities are anticipated in Canada and Mexico due to the rise in medical tourism and an increasing number of hospitals. The Asia Pacific region is projected to experience the highest CAGR in the coming years.

Scope of the Bovine Pericardial Valve Market Report

Recent Developments in the Bovine Pericardial Valve Market

The Bovine Pericardial Valve Market is assessed through qualitative and quantitative data collected from primary and secondary research, including significant corporate publications, association data, and databases. Recent developments in the bovine pericardial valve market include:

Medtronic introduced the Avalus Ultra valve, designed for ease of use during implantation and long-term patient management. This next-generation surgical aortic tissue valve features a polyetheretherketone (PEEK) base frame for consistent circularity, an industry-leading Effective Orifice Area (EOA) for enhanced blood flow, and a radiopaque coil for improved visibility during future valve-in-valve procedures (Source: Medtronic, Press Release, 2024).
Edwards Lifesciences Corporation launched the SAPIEN 3 Ultra RESILIA valve, which integrates the company's RESILIA tissue technology with the SAPIEN 3 Ultra transcatheter aortic heart valve. RESILIA tissue is treated bovine pericardial tissue with advanced anti-calcification technology, serving as the foundation for new valves, including the next-generation SAPIEN X4 valve currently in clinical trials (Source: Edwards Lifesciences, Company Website, 2022).

Coverage and Deliverables of the Bovine Pericardial Valve Market Report

The report titled "Bovine Pericardial Valve Market Size and Forecast (2021-2031)" provides a comprehensive analysis of the market, covering the following areas:

Market size and forecast at global, regional, and country levels for all key segments included in the scope.
Market dynamics, including drivers, restraints, and key opportunities.
Key future trends.
Detailed PEST/Porter's Five Forces and SWOT analysis.
Global and regional market analysis, highlighting key trends, major players, regulations, and recent developments.
Industry landscape and competition analysis, including market concentration, heat map analysis, prominent players, and recent developments.
In-depth company profiles.

1. Introduction

1.1 Scope of theStudy
1.2 The InsightPartners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Bovine Pericardial Valve Market and By Valve Type
- 1.3.2 Bovine Pericardial Valve Market and By Alloy
- 1.3.3 Bovine Pericardial Valve Market and By End User
- 1.3.4 Global Bovine Pericardial Valve Market and By Geography

2. Bovine Pericardial Valve Market and Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 SecondaryResearch
3.3 Primary Research

4. Bovine Pericardial Valve Market and Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America and PEST Analysis
- 4.2.2 Europe and PEST Analysis
- 4.2.3 Asia Pacific and PEST Analysis
- 4.2.4 Middle East and Africa (MEA) and PEST Analysis
- 4.2.5 South and Central America (SCAM) and PEST Analysis
4.3 Expert Opinion

5. Bovine Pericardial Valve Market and Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Incidence of Cardiovascular Diseases (CVD) and CongenitalHeart Diseases (CHD)
- 5.1.2 Advantages of Tissue Valves over Mechanical Valves
5.2 Market Restraints
- 5.2.1 Limitations Associated with Tissue Based Valves
5.3 MarketOpportunities
- 5.3.1 Developing Healthcare Industry Worldwide
5.4 Future Trends
- 5.4.1 Growing Reimbursement for Cardiac Valve Surgery
5.5 Impact Analysisof Drivers and Restraints

6. Bovine Pericardial Valve Market and Global Analysis

6.1 Global BovinePericardial Valve Market Revenue Forecast And Analysis
6.2 Global BovinePericardial Valve Market, By Geography - Forecast And Analysis
6.3 MarketPositioning of Key Players

7. Bovine Pericardial Valve Market Analysisand by Valve Type

7.1 Overview
7.2 BovinePericardial Valve Market Share, By Valve Type, 2024 and 2031 (%)
- 7.2.1 Bovine Pericardial Valve Market Revenue and Forecasts to 2031, ByValve Type (US$ MN)
7.3 Aortic
- 7.3.1 Overview
- 7.3.2 Aortic Market Revenue and Forecasts to 2031 (US$ Mn)
7.4 Mitral
- 7.4.1 Overview
- 7.4.2 Mitral Market Revenue and Forecasts to 2031 (US$ Mn)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others Market Revenue and Forecasts to 2031 (US$ Mn)

8. Bovine Pericardial Valve Market Analysisand by Alloy

8.1 Overview
8.2 BovinePericardial Valve Market Share, By Alloy, 2024 and 2031 (%)
- 8.2.1 Bovine Pericardial Valve Market Revenue and Forecasts to 2031, ByApplication (US$ Mn)
8.3 Cobalt-Chrome
- 8.3.1 Overview
- 8.3.2 Cobalt-Chrome Market Revenue and Forecasts to 2031 (US$ Mn)
8.4 Titanium
- 8.4.1 Overview
- 8.4.2 Titanium Market Revenue and Forecasts to 2031 (US$ Mn)
8.5 Nickel-Molybdenum
- 8.5.1 Overview
- 8.5.2 Nickel-Molybdenum Market Revenue and Forecasts to 2031 (US$ Mn)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Others Market Revenue and Forecasts to 2031 (US$ Mn)

9. Bovine Pericardial Valve Market Analysisand by End User

9.1 Overview
9.2 BovinePericardial Valve Market Share, By End User, 2024 and 2031 (%)
- 9.2.1 Bovine Pericardial Valve Market Revenue and Forecasts to 2031, ByEnd User (US$ Mn)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals Market Revenue and Forecasts to 2031 (US$ Mn)
9.4 Cardiac Centers
- 9.4.1 Overview
- 9.4.2 Cardiac Centers Market Revenue and Forecasts to 2031 (US$ Mn)
9.5 AmbulatorySurgical Centers
- 9.5.1 Overview
- 9.5.2 Ambulatory Surgical Centers Market Revenue and Forecasts to 2031(US$ Mn)

10. Bovine Pericardial Valve Market Analysis And Forecasts To 2031 andGeographical Analysis

10.1 North America:Bovine Pericardial Valve Market
- 10.1.1 Overview
- 10.1.2 North America: Bovine Pericardial Valve Market and Revenue andForecast to 2031 (USD Million)
- 10.1.3 North America: Bovine Pericardial Valve Market, by Valve Type,2024 and 2031 (USD Million)
- 10.1.4 North America: Bovine Pericardial Valve Market, by Alloy, 2024 and 2031(USD Million)
- 10.1.5 North America: Bovine Pericardial Valve Market, by End-User, 2024 and 2031(USD Million)
- 10.1.6 North America: Bovine Pericardial Valve Market, by Country,2024 and 2031 (%)
- 10.1.7 US: Bovine Pericardial Valve Market and Revenue and Forecast to 2031(USD Million)
  - 10.1.7.1 US: Bovine Pericardial Valve Market and Revenue and Forecast to 2031(USD Million)
  - 10.1.7.2 US: Bovine Pericardial Valve Market, by Valve Type, 2024 and 2031 (USDMillion)
  - 10.1.7.3 US: Bovine Pericardial Valve Market, by Alloy, 2024 and 2031 (USDMillion)
  - 10.1.7.4 US: Bovine Pericardial Valve Market, by End-User, 2024 and 2031 (USDMillion)
- 10.1.8 Canada: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.1.8.1 Canada: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.1.8.2 Canada: Bovine Pericardial Valve Market, by Valve Type, 2024 and 2031(USD Million)
  - 10.1.8.3 Canada: Bovine Pericardial Valve Market, by Alloy, 2024 and 2031 (USDMillion)
  - 10.1.8.4 Canada: Bovine Pericardial Valve Market, by End-User, 2024 and 2031 (USDMillion)
- 10.1.9 Mexico: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.1.9.1 Mexico: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.1.9.2 Mexico: Bovine Pericardial Valve Market, by Valve Type, 2024 and 2031(USD Million)
  - 10.1.9.3 Mexico: Bovine Pericardial Valve Market, by Alloy, 2024 and 2031 (USDMillion)
  - 10.1.9.4 Mexico: Bovine Pericardial Valve Market, by End-User, 2024 and 2031 (USDMillion)
10.2 Europe: BovinePericardial Valve Market
- 10.2.1 Overview
- 10.2.2 Europe: Bovine Pericardial Valve Market - Revenue and Forecast to2031 (USD Million)
- 10.2.3 Europe Bovine Pericardial Valve Market, by Valve Type and Revenue andForecast to 2031 (USD Million)
- 10.2.4 Europe Bovine Pericardial Valve Market, by Alloy and Revenue andForecast to 2031 (USD Million)
- 10.2.5 Europe Bovine Pericardial Valve Market, by End User and Revenue andForecast to 2031 (USD Million)
- 10.2.6 Europe: Bovine Pericardial Valve Market, by Country, 2024 and 2031(%)
- 10.2.7 Germany: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.2.7.1 Germany: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.2.7.2 Germany Bovine Pericardial Valve Market, by Valve Type and Revenue and Forecast to 2031 (USD Million)
  - 10.2.7.3 Germany Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.2.7.4 Germany Bovine Pericardial Valve Market, by End User and Revenue and Forecast to 2031 (USD Million)
- 10.2.8 UK: Bovine Pericardial Valve Market and Revenue and Forecast to 2031(USD Million)
  - 10.2.8.1 UK: Bovine Pericardial Valve Market and Revenue and Forecast to 2031(USD Million)
  - 10.2.8.2 UK Bovine Pericardial Valve Market, by Valve Type and Revenue and Forecast to 2031 (USD Million)
  - 10.2.8.3 UK Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.2.8.4 UK Bovine Pericardial Valve Market, by End User and Revenue and Forecast to 2031 (USD Million)
- 10.2.9 France: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.2.9.1 France: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.2.9.2 France Bovine Pericardial Valve Market, by Valve Type and Revenue and Forecast to 2031 (USD Million)
  - 10.2.9.3 France Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.2.9.4 France Bovine Pericardial Valve Market, by End User and Revenue and Forecast to 2031 (USD Million)
- 10.2.10 Spain: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.2.10.1 Spain: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.2.10.2 Spain Bovine Pericardial Valve Market, by Valve Type and Revenue and Forecast to 2031 (USD Million)
  - 10.2.10.3 Spain Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.2.10.4 Spain Bovine Pericardial Valve Market, by End User and Revenue and Forecast to 2031 (USD Million)
- 10.2.11 Italy: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.2.11.1 Italy: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.2.11.2 Italy Bovine Pericardial Valve Market, by Valve Type and Revenue and Forecast to 2031 (USD Million)
  - 10.2.11.3 Italy Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.2.11.4 Italy Bovine Pericardial Valve Market, by End User and Revenue and Forecast to 2031 (USD Million)
10.3 Asia Pacific: BovinePericardial Valve Market
- 10.3.1 Overview
- 10.3.2 Asia Pacific: Bovine Pericardial Valve Market - Revenue and Forecastto 2031 (USD Million)
- 10.3.3 Asia Pacific Bovine Pericardial Valve Market, by Valve Type andRevenue and Forecast to 2031 (USD Million)
- 10.3.4 Asia Pacific Bovine Pericardial Valve Market, by Alloy and Revenue andForecast to 2031 (USD Million)
- 10.3.5 Asia Pacific Bovine Pericardial Valve Market, by End User and Revenueand Forecast to 2031 (USD Million)
- 10.3.6 Asia Pacific: Bovine Pericardial Valve Market, by Country, 2024 and 2031 (%)
- 10.3.7 China: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.3.7.1 China: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.3.7.2 China Bovine Pericardial Valve Market, by Valve Type and Revenue and Forecast to 2031 (USD Million)
  - 10.3.7.3 China Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.3.7.4 China Bovine Pericardial Valve Market, by End User and Revenue and Forecast to 2031 (USD Million)
- 10.3.8 Japan: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.3.8.1 Japan: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.3.8.2 Japan Bovine Pericardial Valve Market, by Valve Type and Revenue and Forecast to 2031 (USD Million)
  - 10.3.8.3 Japan Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.3.8.4 Japan Bovine Pericardial Valve Market, by End User and Revenue and Forecast to 2031 (USD Million)
- 10.3.9 India: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.3.9.1 India: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.3.9.2 India Bovine Pericardial Valve Market, by Valve Type and Revenue and Forecast to 2031 (USD Million)
  - 10.3.9.3 India Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.3.9.4 India Bovine Pericardial Valve Market, by End User and Revenue and Forecast to 2031 (USD Million)
- 10.3.10 South Korea: Bovine Pericardial Valve Market and Revenue and Forecastto 2031 (USD Million)
  - 10.3.10.1 South Korea: Bovine Pericardial Valve Market and Revenue and Forecastto 2031 (USD Million)
  - 10.3.10.2 South Korea Bovine Pericardial Valve Market, by ValveType and Revenue and Forecast to 2031 (USD Million)
  - 10.3.10.3 South Korea Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.3.10.4 South Korea Bovine Pericardial Valve Market, by EndUser and Revenue and Forecast to 2031 (USD Million)
- 10.3.11 Australia: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.3.11.1 Australia: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.3.11.2 Australia Bovine Pericardial Valve Market, by ValveType and Revenue and Forecast to 2031 (USD Million)
  - 10.3.11.3 Australia Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.3.11.4 Australia Bovine Pericardial Valve Market, by EndUser and Revenue and Forecast to 2031 (USD Million)
10.4 Middle East and Africa: Bovine Pericardial Valve Market
- 10.4.1 Overview
- 10.4.2 Middle East and Africa: Bovine Pericardial Valve Market - Revenueand Forecast to 2031 (US$ Million)
- 10.4.3 Middle East and Africa Bovine Pericardial Valve Market, by ValveType and Revenue and Forecast to 2031 (USDMillion)
- 10.4.4 Middle East and Africa Bovine Pericardial Valve Market, by Alloy andRevenue and Forecast to 2031 (USDMillion)
- 10.4.5 Middle East and Africa Bovine Pericardial Valve Market, by EndUser and Revenue and Forecast to 2031 (USDMillion)
- 10.4.6 Middle East and Africa: Bovine Pericardial Valve Market, byCountry, 2018 and 2031 (%)
- 10.4.7 Saudi Arabia: Bovine Pericardial Valve Market and Revenue and Forecastto 2031 (USD Million)
  - 10.4.7.1 Saudi Arabia: Bovine Pericardial Valve Market and Revenue and Forecastto 2031 (USD Million)
  - 10.4.7.2 Saudi Arabia Bovine Pericardial Valve Market, by ValveType and Revenue and Forecast to 2031 (USD Million)
  - 10.4.7.3 Saudi Arabia Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.4.7.4 Saudi Arabia Bovine Pericardial Valve Market, by EndUser and Revenue and Forecast to 2031 (USD Million)
- 10.4.8 UAE: Bovine Pericardial Valve Market and Revenue and Forecast to 2031(USD Million)
  - 10.4.8.1 UAE: Bovine Pericardial Valve Market and Revenue and Forecast to 2031(USD Million)
  - 10.4.8.2 UAE Bovine Pericardial Valve Market, by Valve Type and Revenue and Forecast to 2031 (USD Million)
  - 10.4.8.3 UAE Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.4.8.4 UAE Bovine Pericardial Valve Market, by End User and Revenue and Forecast to 2031 (USD Million)
- 10.4.9 South Africa: Bovine Pericardial Valve Market and Revenue and Forecastto 2031 (USD Million)
  - 10.4.9.1 South Africa: Bovine Pericardial Valve Market and Revenue and Forecastto 2031 (USD Million)
  - 10.4.9.2 South Africa Bovine Pericardial Valve Market, by ValveType and Revenue and Forecast to 2031 (USD Million)
  - 10.4.9.3 South Africa Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.4.9.4 South Africa Bovine Pericardial Valve Market, by EndUser and Revenue and Forecast to 2031 (USD Million)
10.5 South and CentralAmerica: Bovine Pericardial Valve Market
- 10.5.1 Overview
- 10.5.2 South and Central America: Bovine Pericardial Valve Market and Revenueand Forecast to 2031 (USD Million)
- 10.5.3 South and Central America Bovine Pericardial Valve Market, by ValveType and Revenue and Forecast to 2031 (USD Million)
- 10.5.4 South and Central America Bovine Pericardial Valve Market, by Alloyand Revenue and Forecast to 2031 (USD Million)
- 10.5.5 South and Central America Bovine Pericardial Valve Market, by EndUser and Revenue and Forecast to 2031 (USD Million)
- 10.5.6 South and Central America: Bovine Pericardial Valve Market, byCountry, 2024 and 2031 (%)
- 10.5.7 Brazil: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.5.7.1 Brazil: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.5.7.2 Brazil Bovine Pericardial Valve Market, by Valve Type and Revenue and Forecast to 2031 (USD Million)
  - 10.5.7.3 Brazil Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.5.7.4 Brazil Bovine Pericardial Valve Market, by End User and Revenue and Forecast to 2031 (USD Million)
- 10.5.8 Argentina: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.5.8.1 Argentina: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.5.8.2 Argentina Bovine Pericardial Valve Market, by ValveType and Revenue and Forecast to 2031 (USD Million)
  - 10.5.8.3 Argentina Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.5.8.4 Argentina Bovine Pericardial Valve Market, by EndUser and Revenue and Forecast to 2031 (USD Million)

11. Impact of COVID-19 Pandemic on Global Bovine Pericardial ValveMarket

11.1 North America:Impact Assessment of COVID-19 Pandemic
11.2 Europe: ImpactAssessment Of COVID-19 Pandemic
11.3 Asia-Pacific: ImpactAssessment of COVID-19 Pandemic
11.4 Rest of the World: ImpactAssessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview
12.2 Growth StrategiesDone by the Companies in the Market, (%)
12.3 Organic andInorganic Developments
- 12.3.1 Overview

13. Company Profiles

13.1 Abbott
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 AFFLUENT MEDICAL SA
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Boston ScientificCorporation
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Braile Biomedica
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Edwards LifesciencesCorporation
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Labcor
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 LivaNova PLC
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Medtronic
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Meril Life SciencesPvt. Ltd.
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Valcare Medical
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments

14. Appendix

14.1 Glossary of Terms

02-2729-4219

+886-2-2729-4219

License/价格